Correlation Between ZyVersa Therapeutics and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Tscan Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Tscan Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Tscan Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Tscan is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Tscan Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Tscan Therapeutics. In addition to that, ZyVersa Therapeutics is 1.75 times more volatile than Tscan Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Tscan Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 214.00 in Tscan Therapeutics on August 27, 2024 and sell it today you would earn a total of 212.00 from holding Tscan Therapeutics or generate 99.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Tscan Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Tscan Therapeutics |
ZyVersa Therapeutics and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Tscan Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |